Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000073 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 15, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
21,000
Total Value
$655,177.77
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 15, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 36,218 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 15, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 39,718 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 15, 2026 | Sale | 400 | $84.36 | $33,746.00 | 39,318 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 15, 2026 | Sale | 2,497 | $85.86 | $214,385.43 | 36,821 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 15, 2026 | Sale | 3,803 | $86.68 | $329,630.35 | 33,018 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 15, 2026 | Sale | 300 | $87.25 | $26,175.99 | 32,718 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Jul 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 200,563 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Jul 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 171,992 | Direct | โ | View Details |